Publication related to RSI or an RSI staff member
Association between change of health care providers and pregnancy exposure to FDA category C, D and X drugs.
Authors
- Yang, Jianzhou, Yang J, School of Public Health, Central South University, Changsha, Hunan 410008, China; Department of Preventive Medicine, Changzhi Medical College, Changzhi, Shanxi 046000, China; McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Canada; OMNI Research Group, Department of Obstetrics and Gynecology, University of Ottawa Faculty of Medicine, Ottawa, Canada.
- Xie, Rihua, Xie R, OMNI Research Group, Department of Obstetrics and Gynecology, University of Ottawa Faculty of Medicine, Ottawa, Canada; Huaihua Medical College, Huaihua, Hunan 418000, China.
- Krewski, Daniel, Krewski D, McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Canada.
- Wang, Yongjin, Wang Y, Department of Cardiology, Heping Hospital, Changzhi Medical College, Changzhi, Shanxi 046000, China. Email: yongjinwang2008@sohu.com.
- Walker, Mark, Walker M, OMNI Research Group, Department of Obstetrics and Gynecology, University of Ottawa Faculty of Medicine, Ottawa, Canada; Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Canada.
- Cao, Wenjun, Cao W, Department of Preventive Medicine, Changzhi Medical College, Changzhi, Shanxi 046000, China.
- Wen, Shi Wu, Wen SW, School of Public Health, Central South University, Changsha, Hunan 410008, China; OMNI Research Group, Department of Obstetrics and Gynecology, University of Ottawa Faculty of Medicine, Ottawa, Canada; Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Canada; Department of Epidemiology and Community Medicine, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada. Email: swwen@ohri.ca.
YEAR OF PUBLICATION: 2014
SOURCE: Chin Med J (Engl). 2014;127(4):702-6.
JOURNAL TITLE ABBREVIATION: Chin Med J (Engl)
JOURNAL TITLE: Chinese medical journal
ISSN: 2542-5641 (Electronic) 0366-6999 (Linking)
VOLUME: 127
ISSUE: 4
PAGES: 702-6
PLACE OF PUBLICATION: China
ABSTRACT:
BACKGROUND: Changing health care providers frequently breaks the continuity of care, which is associated with many health care problems. The purpose of this study was to examine the association between a change of health care providers and pregnancy exposure to FDA category C, D and X drugs. METHODS: A 50% random sample of women who gave a birth in Saskatchewan between January 1, 1997 and December 31, 2000 were chosen for this study. The association between the number of changes in health care providers and with pregnancy exposure to category C, D, and X drugs for those women with and without chronic diseases were evaluated using multiple logistical regression, with adjusted odds ratios (ORs) and its 95% confidence intervals (CIs) as the association measures. RESULTS: A total of 18 568 women were included in this study. Rates of FDA C, D, and X drug uses were 14.35%, 17.07%, 21.72%, and 31.14%, in women with no change of provider, 1-2 changes, 3-5 changes, and more than 5 changes of health care providers. An association between the number of changes of health care providers and pregnancy exposure to FDA C, D, and X drugs existed in women without chronic diseases but not in women with chronic disease. CONCLUSION: Change of health care providers is associated with pregnancy exposure to FDA category C, D and X drugs in women without chronic diseases.
BACKGROUND: Changing health care providers frequently breaks the continuity of care, which is associated with many health care problems. The purpose of this study was to examine the association between a change of health care providers and pregnancy exposure to FDA category C, D and X drugs. METHODS: A 50% random sample of women who gave a birth in Saskatchewan between January 1, 1997 and December 31, 2000 were chosen for this study. The association between the number of changes in health care providers and with pregnancy exposure to category C, D, and X drugs for those women with and without chronic diseases were evaluated using multiple logistical regression, with adjusted odds ratios (ORs) and its 95% confidence intervals (CIs) as the association measures. RESULTS: A total of 18 568 women were included in this study. Rates of FDA C, D, and X drug uses were 14.35%, 17.07%, 21.72%, and 31.14%, in women with no change of provider, 1-2 changes, 3-5 changes, and more than 5 changes of health care providers. An association between the number of changes of health care providers and pregnancy exposure to FDA C, D, and X drugs existed in women without chronic diseases but not in women with chronic disease. CONCLUSION: Change of health care providers is associated with pregnancy exposure to FDA category C, D and X drugs in women without chronic diseases.
LANGUAGE: eng
DATE OF PUBLICATION: 2014
DATE COMPLETED: 20150406
DATE REVISED: 20140218
MESH DATE: 2015/04/07 06:00
EDAT: 2014/02/19 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
OWNER: NLM
Related RSI Experts
Chief Risk Scientist
Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...